Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 7/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15151739 | 0.88 | CYP2C19 (0.39) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL29483187 | 0.87 | CYP2C19 (0.40) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL882862 | 0.87 | CYP2C19 (0.38) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL874965 | 0.87 | CYP2C19 (0.40) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL18218315 | 0.84 | CYP2C19 (0.43) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL1228603 | 0.82 | CYP2C19 (0.44) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL20810235 | 0.80 | CYP2C19 (0.42) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL16119877 | 0.80 | CYP2C19 (0.42) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL16119867 | 0.80 | CYP2C19 (0.44) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A | |
| SCHEMBL6565818 | 0.79 | CYP2C19 (0.47) | CYP2C19CYP1A2CYP2D6CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2618662-B1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECH CO (SA) | 2019-11-06 | — | — | EP | disclosed |
| US-10442816-B2 | Synthesis of substituted salicylaldehyde derivatives | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2019-10-15 | — | — | US | disclosed |
| US-10040800-B2 | Synthesis of substituted salicylaldehyde derivatives | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-08-07 | — | — | US | disclosed |
| US-10040800-B2 | Synthesis of substituted salicylaldehyde derivatives | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2018-08-07 | — | — | US | disclosed |
| US-20160257695-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2016-09-08 | — | — | US | disclosed |
| US-20160257695-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2016-09-08 | — | — | US | disclosed |
| US-9371334-B2 | Synthesis of substituted salicylaldehyde derivatives | NOVOMER, INC. (US) | 2016-06-21 | — | — | US | disclosed |
| US-9371334-B2 | Synthesis of substituted salicylaldehyde derivatives | NOVOMER, INC. (US) | 2016-06-21 | — | — | US | disclosed |
| US-20150011761-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2015-01-08 | — | — | US | disclosed |
| US-20150011761-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2015-01-08 | — | — | US | disclosed |
| US-8859822-B2 | Synthesis of substituted salicylaldehyde derivatives | NOVOMER, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| US-8859822-B2 | Synthesis of substituted salicylaldehyde derivatives | NOVOMER, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| US-20130197223-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | NOVOMER, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| US-20130197223-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | NOVOMER, INC. (US) | 2013-08-01 | — | — | US | disclosed |
| WO-2012040454-A2 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | NOVOMER, INC. (US) | 2012-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160257695-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | ADSL, ALDH3A1, SUCLA2 | CYP2C19 2339/4885CYP1A2 1013/4885CYP2D6 770/4885 |
| US-10442816-B2 | Synthesis of substituted salicylaldehyde derivatives | ADSL, ALDH3A1, SUCLA2 | CYP2C19 2339/4885CYP1A2 1013/4885CYP2D6 770/4885 |
| US-10040800-B2 | Synthesis of substituted salicylaldehyde derivatives | ADSL, ALDH3A1, SUCLA2 | CYP2C19 2339/4885CYP1A2 1013/4885CYP2D6 770/4885 |
| US-20150011761-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | ADSL, ALDH3A1, SUCLA2 | CYP2C19 2339/4885CYP1A2 1013/4885CYP2D6 770/4885 |
| US-20130197223-A1 | SYNTHESIS OF SUBSTITUTED SALICYLALDEHYDE DERIVATIVES | ADSL, ALDH3A1, SUCLA2 | CYP2C19 2339/4885CYP1A2 1013/4885CYP2D6 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.